Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates K.M.T. Astvad, R.K. Hare, M.C. Arendrup Clinical Microbiology and Infection Volume 23, Issue 11, Pages 882-887 (November 2017) DOI: 10.1016/j.cmi.2017.03.023 Copyright © 2017 The Author(s) Terms and Conditions
Fig. 1 MIC distributions for selected Candida species. Clinical Microbiology and Infection 2017 23, 882-887DOI: (10.1016/j.cmi.2017.03.023) Copyright © 2017 The Author(s) Terms and Conditions
Fig. 2 MIC distributions for selected Aspergillus species and Aspergillus fumigatus CYP51A genotypes. Clinical Microbiology and Infection 2017 23, 882-887DOI: (10.1016/j.cmi.2017.03.023) Copyright © 2017 The Author(s) Terms and Conditions